{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T01:27:40Z","timestamp":1785374860291,"version":"3.55.0"},"reference-count":20,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T00:00:00Z","timestamp":1559347200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,2,19]],"date-time":"2019-02-19T00:00:00Z","timestamp":1550534400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100007819","name":"Allergan plc","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100007819","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Global Antimicrobial Resistance"],"published-print":{"date-parts":[[2019,6]]},"DOI":"10.1016\/j.jgar.2019.02.007","type":"journal-article","created":{"date-parts":[[2019,2,23]],"date-time":"2019-02-23T13:24:01Z","timestamp":1550928241000},"page":"60-65","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":39,"special_numbering":"C","title":["Single-dose dalbavancin and patient satisfaction in an outpatient setting in the treatment of acute bacterial skin and skin structure infections"],"prefix":"10.1016","volume":"17","author":[{"given":"Urania","family":"Rappo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pedro L.","family":"Gonzalez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sailaja","family":"Puttagunta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karthik","family":"Akinapelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katelyn","family":"Keyloun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick","family":"Gillard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael W.","family":"Dunne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jgar.2019.02.007_bib0005","doi-asserted-by":"crossref","first-page":"1585","DOI":"10.1001\/archinte.168.14.1585","article-title":"National trends in ambulatory visits and antibiotic prescribing for skin and soft-tissue infections","volume":"168","author":"Hersh","year":"2008","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.jgar.2019.02.007_bib0010","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/j.annemergmed.2007.12.004","article-title":"Increased US emergency department visits for skin and soft tissue infections, and changes in antibiotic choices, during the emergence of community-associated methicillin-resistant Staphylococcus aureus","volume":"51","author":"Pallin","year":"2008","journal-title":"Ann Emerg Med"},{"key":"10.1016\/j.jgar.2019.02.007_bib0015","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1080\/17512433.2016.1195683","article-title":"Transitions of care in the management of acute bacterial skin and skin structure infections: a paradigm shift","volume":"9","author":"Verastegui","year":"2016","journal-title":"Expert Rev Clin Pharmacol"},{"key":"10.1016\/j.jgar.2019.02.007_bib0020","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.3111\/13696998.2015.1078339","article-title":"Assessing the economic value of avoiding hospital admissions by shifting the management of gram+ acute bacterial skin and skin structure infections to an outpatient care setting","volume":"18","author":"Ektare","year":"2015","journal-title":"J Med Econ"},{"key":"10.1016\/j.jgar.2019.02.007_bib0025","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/j.ijantimicag.2015.07.001","article-title":"The history and evolution of outpatient parenteral antibiotic therapy (OPAT)","volume":"46","author":"Williams","year":"2015","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.jgar.2019.02.007_bib0030","series-title":"Dalvance\u00ae (dalbavancin). Full prescribing information","year":"2017"},{"key":"10.1016\/j.jgar.2019.02.007_bib0035","series-title":"Xydalba\u2122 (dalbavancin). Full prescribing information","year":"2016"},{"key":"10.1016\/j.jgar.2019.02.007_bib0040","doi-asserted-by":"crossref","first-page":"2169","DOI":"10.1056\/NEJMoa1310480","article-title":"Once-weekly dalbavancin versus daily conventional therapy for skin infection","volume":"370","author":"Boucher","year":"2014","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jgar.2019.02.007_bib0045","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1093\/cid\/civ982","article-title":"A randomized clinical trial of single-dose versus weekly dalbavancin for treatment of acute bacterial skin and skin structure infection","volume":"62","author":"Dunne","year":"2016","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jgar.2019.02.007_bib0050","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1007\/s40265-015-0430-x","article-title":"Dalbavancin: a review in acute bacterial skin and skin structure infections","volume":"75","author":"Scott","year":"2015","journal-title":"Drugs"},{"key":"10.1016\/j.jgar.2019.02.007_bib0055","unstructured":"Centers for Medicare & Medicaid Services. HCAHPS: patients\u2019 perspectives of care survey. http:\/\/www.cms.gov\/Medicare\/Quality-Initiatives-Patient-Assessment-Instruments\/HospitalQualityInits\/HospitalHCAHPS.html. [Accessed 12 June 2018]."},{"key":"10.1016\/j.jgar.2019.02.007_bib0060","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1093\/jac\/dkp343","article-title":"Clinical efficacy and cost-effectiveness of outpatient parenteral antibiotic therapy (OPAT): a UK perspective","volume":"64","author":"Chapman","year":"2009","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.jgar.2019.02.007_bib0065","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1007\/s10096-009-0794-5","article-title":"Self-administered outpatient parenteral antimicrobial therapy: a report of three years experience in the Irish healthcare setting","volume":"28","author":"Kieran","year":"2009","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1016\/j.jgar.2019.02.007_bib0070","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1080\/23744235.2017.1296968","article-title":"Review of the pharmacokinetics of dalbavancin, a recently approved lipoglycopeptide antibiotic","volume":"49","author":"Dash","year":"2017","journal-title":"Infect Dis (Lond)"},{"key":"10.1016\/j.jgar.2019.02.007_bib0075","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1016\/j.jemermed.2014.12.001","article-title":"Acute bacterial skin and skin structure infections (ABSSSI): practice guidelines for management and care transitions in the emergency department and hospital","volume":"48","author":"Pollack","year":"2015","journal-title":"J Emerg Med"},{"key":"10.1016\/j.jgar.2019.02.007_bib0080","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.ijantimicag.2017.03.016","article-title":"Clinical efficacy, cost analysis and patient acceptability of outpatient parenteral antibiotic therapy (OPAT): a decade of Sheffield (UK) OPAT service","volume":"51","author":"Durojaiye","year":"2018","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.jgar.2019.02.007_bib0085","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1007\/s10096-017-2944-5","article-title":"Patient satisfaction in an outpatient parenteral antimicrobial therapy (OPAT) unit practising predominantly self-administration of antibiotics with elastomeric pumps","volume":"36","author":"Saillen","year":"2017","journal-title":"Eur J Clin Microbiol Infect Dis"},{"issue":"59","key":"10.1016\/j.jgar.2019.02.007_bib0090","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1093\/cid\/ciu444","article-title":"Practice guidelines for the diagnosis and management of skin and soft tissue infections: 2014 update by the Infectious Diseases Society of America","author":"Stevens","year":"2014","journal-title":"Clin Infect Dis"},{"issue":"43","key":"10.1016\/j.jgar.2019.02.007_bib0095","first-page":"137","article-title":"Hospital admission patterns in adult patients with skin and soft tissue infections: identification of potentially avoidable hospital admissions through a retrospective database analysis","volume":"2015","author":"Lodise","year":"1995","journal-title":"Hosp Pract"},{"key":"10.1016\/j.jgar.2019.02.007_bib0100","doi-asserted-by":"crossref","first-page":"89","DOI":"10.5811\/westjem.2014.11.24133","article-title":"Factors associated with decision to hospitalize emergency department patients with skin and soft tissue infection","volume":"16","author":"Talan","year":"2015","journal-title":"West J Emerg Med"}],"container-title":["Journal of Global Antimicrobial Resistance"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213716519300475?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213716519300475?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,6,18]],"date-time":"2019-06-18T16:47:27Z","timestamp":1560876447000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213716519300475"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,6]]},"references-count":20,"alternative-id":["S2213716519300475"],"URL":"https:\/\/doi.org\/10.1016\/j.jgar.2019.02.007","relation":{},"ISSN":["2213-7165"],"issn-type":[{"value":"2213-7165","type":"print"}],"subject":[],"published":{"date-parts":[[2019,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Single-dose dalbavancin and patient satisfaction in an outpatient setting in the treatment of acute bacterial skin and skin structure infections","name":"articletitle","label":"Article Title"},{"value":"Journal of Global Antimicrobial Resistance","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jgar.2019.02.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 The Author(s). Published by Elsevier Ltd on behalf of International Society for Chemotherapy of Infection and Cancer.","name":"copyright","label":"Copyright"}]}}